These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1702963)

  • 1. [Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].
    Flam T; Géraud M; Zerbib M; Debré B; Steg A
    Ann Urol (Paris); 1990; 24(6):530-2. PubMed ID: 1702963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic ureteroneocystostomy: palliative urinary diversion in advanced prostatic cancer.
    Chefchaouni MC; Flam TA; Pacha K; Thiounn N; Zerbib M; Debré B
    Tech Urol; 1998 Mar; 4(1):46-50. PubMed ID: 9568777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of percutaneous nephrostomy in patients with ureteric obstruction undergoing renal transplantation.
    Ehrlichman RJ; Bettman M; Kirkman RL; Tilney NL
    Surg Gynecol Obstet; 1986 Feb; 162(2):121-5. PubMed ID: 3511554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Palliative urinary diversion in inoperable pelvic tumors].
    Olivo JF; Le Joliff L; Artagnan J; Lobel B
    J Urol (Paris); 1987; 93(6):353-5. PubMed ID: 2448387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic management of bilateral ureteral obstruction after radiotherapy].
    Zeng GH; Li X; Wu KJ; Chen WZ
    Ai Zheng; 2004 Jan; 23(1):108-9. PubMed ID: 14720387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Internal urinary diversion in pelvic cancers and quality of life. Value of double "J" endoprosthesis].
    Giannakopoulos X; Gartzios A; Giannakis D; Tsamboulas K; Kotoulas K
    J Urol (Paris); 1995; 101(5-6):221-7. PubMed ID: 8761875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of transurethral resection in cancer of the prostate].
    Rodríguez JV; Chechile G
    Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
    Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
    Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallic ureteric stents: early experience.
    Pandian SS; Hussey JK; McClinton S
    Br J Urol; 1998 Dec; 82(6):791-7. PubMed ID: 9883213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy palliation in malignancy-associated ureteral obstruction.
    Ampil FL
    Radiat Med; 1989; 7(6):282-6. PubMed ID: 2483756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous urinary drainage and ureteric stenting in malignant disease.
    Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.